Pariani Elena, Amendola Antonella, Tanzi Elisabetta, Zanetti Alessandro
Department of Public Health-Microbiology-Virology, University of Milan, Milan, Italy.
Vaccine. 2009 May 26;27(25-26):3342-4. doi: 10.1016/j.vaccine.2009.01.082. Epub 2009 Feb 5.
Morbidity and mortality related to influenza are highest among people aged 65 and above, and among people of any age who have medical conditions that place them at increased risk of influenza complications, including hospitalisation and death. Influenza vaccination is the most effective tool for preventing influenza both in terms of cost-effectiveness and benefit-cost ratios. Given the health benefits of influenza vaccination in preventing the disease and its potentially severe complications, recommendations that focus on providing annual vaccination targeted to people at increased risk have been implemented, but coverage among these groups is still well below the Italian health authorities' goals.
与流感相关的发病率和死亡率在65岁及以上人群中最高,在任何年龄段患有使他们面临流感并发症(包括住院和死亡)风险增加的疾病的人群中也最高。就成本效益和效益成本比而言,流感疫苗接种是预防流感最有效的工具。鉴于流感疫苗接种在预防疾病及其潜在严重并发症方面的健康益处,已实施了针对高风险人群提供年度疫苗接种的建议,但这些人群中的接种率仍远低于意大利卫生当局的目标。